Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial
dc.contributor.author | Olldashi, F. | |
dc.contributor.author | Kerçi, M. | |
dc.contributor.author | Dakubo, J.C.B. | |
dc.contributor.author | Ruçi, K. | |
dc.contributor.author | Banushi, A. | |
dc.contributor.author | Traverso, M.S. | |
dc.contributor.author | Chengo, C. | |
dc.date.accessioned | 2013-06-18T16:37:51Z | |
dc.date.accessioned | 2017-10-19T13:08:22Z | |
dc.date.available | 2013-06-18T16:37:51Z | |
dc.date.available | 2017-10-19T13:08:22Z | |
dc.date.issued | 2010 | |
dc.identifier.uri | http://197.255.68.203/handle/123456789/3595 | |
dc.language.iso | en | en_US |
dc.publisher | The Lancet | en_US |
dc.title | Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial | en_US |
dc.type | Article | en_US |